Back

Multisite longitudinal efficacy trial of a disclosure intervention (TRACK) for HIV+ mothers: An update

Murphy, D. A.; Marelich, W. D.; Armistead, L.; Schulte, M. T.

2022-08-30 hiv aids
10.1101/2022.08.26.22278479 medRxiv
Show abstract

BackgroundThe Teaching, Raising, And Communicating with Kids (TRACK) intervention full-scale longitudinal efficacy trial was published in 2021 and was based on a previously successful pilot intervention published in 2011. The TRACK intervention assists mothers living with HIV (MLH) with serostatus disclosure to their young children. In the publication reporting the full-scale trial, TRACK MLH were four times more likely to disclose their HIV serostatus than controls, with the rate increasing to six times more likely applying GEE logistic regression. Intervention MLH showed improvements in communication, social support, family routines, and disclosure self-efficacy; they also demonstrated decreased anxiety and better physical and mental health scores; and their children reported significantly more decline in worry than controls. MethodsThis preprint presents recent analyses showing increases in the reported HIV disclosure rates over and above those reported in the full-scale trial, due to additional follow-up datapoints received after the 2021 publication. ResultsFor MLH in the intervention group, disclosure is 37.6% compared to 34.1% from the 2021 publication, and 12.1% in the control condition compared to 11%. Odds of disclosing if participants were in the intervention group are 4.39 (95% CI. = 2.0, 9.5) compared to 4.20 (95% CI. = 1.8, 9.3), with the intervention group 30% more likely to disclose compared to the 28% reported in 2021. Regarding site disclosure rates for the intervention group, the California disclosure rate is 43.6% compared to 35.9% previously reported; Georgias site rate remained unchanged. ConclusionsThese updates are now included in our final analysis dataset and show the intervention was more successful than previously reported.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
JAIDS Journal of Acquired Immune Deficiency Syndromes
19 papers in training set
Top 0.1%
22.4%
2
PLOS ONE
4510 papers in training set
Top 13%
14.6%
3
AIDS and Behavior
14 papers in training set
Top 0.1%
14.3%
50% of probability mass above
4
BMJ Open
554 papers in training set
Top 2%
8.4%
5
PLOS Medicine
98 papers in training set
Top 0.5%
6.3%
6
Journal of the International AIDS Society
20 papers in training set
Top 0.1%
4.3%
7
Journal of Medical Internet Research
85 papers in training set
Top 1%
3.6%
8
AIDS
31 papers in training set
Top 0.2%
2.3%
9
JMIR Research Protocols
18 papers in training set
Top 0.4%
2.3%
10
JAMA Network Open
127 papers in training set
Top 2%
1.9%
11
BMJ Global Health
98 papers in training set
Top 2%
1.5%
12
International Journal of Environmental Research and Public Health
124 papers in training set
Top 5%
1.2%
13
Clinical Infectious Diseases
231 papers in training set
Top 3%
1.2%
14
Addiction
25 papers in training set
Top 0.3%
0.9%
15
BMC Public Health
147 papers in training set
Top 5%
0.9%
16
Pilot and Feasibility Studies
12 papers in training set
Top 0.6%
0.8%
17
Nature Human Behaviour
85 papers in training set
Top 4%
0.8%
18
BMJ Public Health
18 papers in training set
Top 0.7%
0.7%
19
Open Forum Infectious Diseases
134 papers in training set
Top 3%
0.7%
20
BMC Infectious Diseases
118 papers in training set
Top 5%
0.7%
21
American Journal of Epidemiology
57 papers in training set
Top 1%
0.7%
22
Peer Community Journal
254 papers in training set
Top 4%
0.7%
23
PLOS Global Public Health
293 papers in training set
Top 6%
0.6%
24
International Journal of Medical Informatics
25 papers in training set
Top 2%
0.6%
25
eClinicalMedicine
55 papers in training set
Top 2%
0.6%